Efficacy and safety of a daytime anxiolytic containing technologically processed antibodies to the S100 protein. Overview of clinical studies

The review presents the results of clinical studies of the efficacy and safety of Tenoten and Tenoten children’s in the treatment of anxiety, neurotic, stress-related and somatoform disorders and adjustment disorders. Technologically processed antibodies to the S100 protein in Tenoten and Tenoten ch...

Full description

Bibliographic Details

Published in:	Неврология, нейропсихиатрия, психосоматика
Main Authors:	M. Perez, N. N. Zavadenko, L. A. Skipetrova, I. I. Smirnov, Yu. E. Nesterovskiy
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2023-07-01
Subjects:	tenoten tenoten children’s neurotic and neurosis-like disorders anxiety disorders neuroinflammation daytime anxiolytic
Online Access:	https://nnp.ima-press.net/nnp/article/view/2038